Back to Newsroom

ProMIS Neurosciences Chief Scientific Officer, Dr. Neil Cashman, to Present at Third Annual R&D Technologies Conference

TORONTO, Ontario and CAMBRIDGE, Massachusetts – September 28, 2017– ProMIS Neurosciences, Inc., a biotechnology company focused on the discovery and development of precision treatments for neurodegenerative diseases, announced that Neil Cashman, MD, Professor and Canada Research Chair, University of British Columbia and Chief Scientific Officer, ProMIS Neurosciences, will present today at the 3rd Annual Neuroscience R&D Technologies Conference: Exploring Cutting-edge Technologies in Pre-clinical Neuroscience  Studies.